Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine.

< BACK TO ARCHIVE


Papers: 27 Feb 2021 - 5 Mar 2021


Human Studies

PAIN TYPE:
Migraine/Headache


2021 Feb 28


Pain Med


http://www.ncbi.nlm.nih.gov/pubmed/33659991?dopt=Abstract

Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine.

Authors

Evaluation of the Impact of the COVID-19 Lockdown in the Clinical Course of Migraine.
Gonzalez-Martinez A, Planchuelo-Gómez Á, Guerrero ÁL, García-Azorín D, Santos-Lasaosa S, Pilar Navarro-Pérez M, Odriozola-González P, Irurtia M J, Quintas S, de Luis-García R, Gago-Veiga A B
Pain Med. 2021 Feb 28.
PMID: 33659991.

Abstract

Previous studies have demonstrated that emotional stress, changes in lifestyle habits and infections can worsen the clinical course of migraine. We hypothesize that changes in habits and medical care during coronavirus disease 2019 (COVID-19) lockdown might have worsened the clinical course of migraine.
Read This Paper